CDKN1B and prostate cancer: A treatment with SB in prostate cancer cells resulted in an induced expression of p21 and p27 and effectively inhibited the proliferation of these cells (12) and moreover in H1299 lung carcinoma cells an upregulation of p21 and cell cycle arrest after SB treatment was found (33).